{"@name":"rebirthel-com","@path":"/japan/rebirthel-com","@id":"28145955-e9b9-4d0b-9552-82fcd73f58d7","@nodeType":"mt:startup","jcr:createdBy":"admin","startupLongitude":"","startupLatitude":"","startupCountry":{"@name":"japan","@path":"/plug-and-play/japan","@id":"b98d0089-3f4f-4b58-b01b-782a9f73fa9d","@nodeType":"mt:country","slug":"japan","jcr:createdBy":"admin","jcr:mixinTypes":["mix:versionable","mgnl:hasVersion"],"jcr:created":"2024-06-11T06:38:55.041Z","countryContinent":"Asia","mgnl:created":"2024-06-06T08:38:53.298Z","countrySortingOrder":"1","countryName":"Japan","mgnl:createdBy":"pnptc","jcr:predecessors":["b2c8b61e-543c-49b7-a542-aa2a405bb5f3"],"jcr:baseVersion":"b2c8b61e-543c-49b7-a542-aa2a405bb5f3","mgnl:comment":"","mgnl:lastModified":"2026-05-21T03:28:51.114Z","countryRegion":"Asia","jcr:isCheckedOut":true,"mgnl:lastModifiedBy":"k.hattori@pnptc.com","jcr:versionHistory":"95ea2be2-ab93-4ba6-9b19-d8f6fef64678","@link":"https://public.dxp.playbook.vc/plug-and-play/japan.html","@nodes":[]},"mgnl:created":"2026-04-21T14:55:57.118Z","startupUnicorn":false,"startupPlaybookID":"91190","startupIndustriesList-search":"fff86da1-0d1b-44a1-aa17-137435875106","startupAccelerated":false,"startupExit":false,"startupDescription":"\"Rebirthel is a pioneering biotech company focused on the development and operationalization of cell-based cancer immunotherapies. \n\nUtilizing cutting-edge technology developed by Dr. Hiroshi Kawamoto, Director of the Institute for Frontier Medical Sciences at Kyoto University, Rebirthel aims to provide innovative treatments for immune-related diseases such as cancer and infections. \n\nThe company specializes in producing killer T cells derived from pluripotent stem cells, offering a novel approach to immunotherapy. By focusing on the production of allogeneic T cells that can be administered to anyone, Rebirthel is revolutionizing the field of immunotherapy.\n\nWith a vision to pioneer the era of treating diseases with T cell products, Rebirthel is at the forefront of the immunotherapy industry. Leveraging patented technology, the company is dedicated to providing advanced treatments using killer T cells regenerated from pluripotent stem cells, striving to offer cutting-edge therapies for patients in need.\"","slug":"rebirthel-com","startupMainIndustry":{"@name":"medtech","@path":"/plug-and-play/medtech","@id":"fff86da1-0d1b-44a1-aa17-137435875106","@nodeType":"mt:industries","industryLastInsightMain":"a0b0bcef-a8b0-4251-8b00-eaa5109d7837","slug":"medtech","jcr:createdBy":"admin","industryIsActive":true,"name":"medtech","jcr:mixinTypes":["mgnl:hasVersion"],"jcr:created":"2024-06-02T00:05:51.629Z","mgnl:created":"2024-05-20T22:28:41.503Z","industryTitle":"Medtech","mgnl:createdBy":"ajerrom","industryDetailPage":"cf38f255-b04e-4001-9fb8-3f6dabbb1435","mgnl:lastModified":"2026-04-14T13:50:45.869Z","industryImage":"jcr:f999dd54-4d38-4e87-853b-e0681b2d7184","mgnl:lastModifiedBy":"pnptc","@link":"https://public.dxp.playbook.vc/plug-and-play/medtech.html","@nodes":[]},"startupLocation":{"@name":"tokyo","@path":"/plug-and-play/tokyo","@id":"3323e74c-ecb6-4202-9c7f-71dfba5a0092","@nodeType":"mt:locations","jcr:createdBy":"admin","locationState":"Japan","locationTitle":"Tokyo, Japan","name":"tokyo","mgnl:created":"2024-06-04T09:01:59.480Z","locationLinkedin":"https://www.linkedin.com/company/plugandplayjapan/","jcr:baseVersion":"c9d95be2-e1e7-47c2-93cf-d82c93f453a0","locationIsActive":true,"locationCity":"Tokyo","locationAddress":"3 Chome-12 Shibuya","jcr:versionHistory":"602efbe5-cf27-4763-9699-964157f9cb27","slug":"tokyo","locationMapLongitude":"139.6984865952797","locationMapLatitude":"35.65702868601926","locationDetailPage":"6614b460-dbe0-40ef-a547-893e7359f045","jcr:mixinTypes":["mix:versionable","mgnl:hasVersion"],"jcr:created":"2024-06-11T06:54:23.889Z","locationAdress":"Shibuya Dogenzaka Tokyu Building | 1F, 1-10-8 Dogenzaka, Shibuya-ku, Tokyo 150-0043, Japan","mgnl:createdBy":"amarin","jcr:predecessors":["c9d95be2-e1e7-47c2-93cf-d82c93f453a0"],"mgnl:comment":"","mgnl:lastModified":"2026-06-29T17:35:51.797Z","jcr:isCheckedOut":true,"locationCountry":"b98d0089-3f4f-4b58-b01b-782a9f73fa9d","mgnl:lastModifiedBy":"ajerrom","locationImage":"jcr:fe611d48-83e0-419c-862b-5983797835d5","@link":"https://public.dxp.playbook.vc/plug-and-play/tokyo.html","locationPartnersList":{"@name":"locationPartnersList","@path":"/plug-and-play/tokyo/locationPartnersList","@id":"e57c1ac7-e182-41b4-b394-0138f0d555e8","@nodeType":"mgnl:contentNode","mgnl:createdBy":"ajerrom","jcr:createdBy":"admin","mgnl:lastModified":"2026-04-14T13:50:48.322Z","jcr:created":"2026-06-29T17:35:54.995Z","mgnl:created":"2024-06-04T10:43:29.335Z","mgnl:lastModifiedBy":"pnptc","@nodes":[]},"locationIndustriesList":{"@name":"locationIndustriesList","@path":"/plug-and-play/tokyo/locationIndustriesList","@id":"b18f69d4-2f31-4f47-aac2-4dbed6c68e45","@nodeType":"mgnl:contentNode","mgnl:createdBy":"ajerrom","jcr:createdBy":"admin","mgnl:lastModified":"2026-04-14T13:50:48.322Z","jcr:created":"2026-06-29T17:35:54.996Z","mgnl:created":"2024-06-12T15:10:19.040Z","mgnl:lastModifiedBy":"pnptc","@nodes":[]},"@nodes":["locationPartnersList","locationIndustriesList"]},"startupBatchesList-search":"","startupTitle":"リバーセル株式会社","startupOneLiner":"Rebirthel is a biotech company, focused on the Development and operationalization of cell-based cancer immunotherapies.","startupWebsite":"https://rebirthel.com/","jcr:mixinTypes":["mgnl:hasVersion"],"jcr:created":"2026-05-06T11:21:22.495Z","startupLogo":"https://cdn.playbook.vc/media/startup-no-logo-placeholder.png","mgnl:createdBy":"pnp-rest-admin","mgnl:lastModified":"2026-04-21T14:56:02.481Z","startupIsActive":true,"startupPortfolio":false,"mgnl:lastModifiedBy":"superuser","startupIndustriesList":{"@name":"startupIndustriesList","@path":"/japan/rebirthel-com/startupIndustriesList","@id":"7ac8371e-034b-43c7-9d8d-b4e90a9f0823","@nodeType":"mgnl:contentNode","mgnl:createdBy":"pnp-rest-admin","jcr:createdBy":"admin","startupBatchesList-search":"","mgnl:lastModified":"2026-04-21T14:56:01.454Z","jcr:created":"2026-05-06T11:21:33.880Z","mgnl:created":"2026-04-21T14:56:00.419Z","mgnl:lastModifiedBy":"superuser","fff86da1-0d1b-44a1-aa17-137435875106":{"@name":"fff86da1-0d1b-44a1-aa17-137435875106","@path":"/japan/rebirthel-com/startupIndustriesList/fff86da1-0d1b-44a1-aa17-137435875106","@id":"437d2456-cafc-4137-8594-2a24e15f9c7c","@nodeType":"mgnl:contentNode","mgnl:createdBy":"pnp-rest-admin","jcr:createdBy":"admin","startupIndustry":{"@name":"medtech","@path":"/plug-and-play/medtech","@id":"fff86da1-0d1b-44a1-aa17-137435875106","@nodeType":"mt:industries","industryLastInsightMain":"a0b0bcef-a8b0-4251-8b00-eaa5109d7837","slug":"medtech","jcr:createdBy":"admin","industryIsActive":true,"name":"medtech","jcr:mixinTypes":["mgnl:hasVersion"],"jcr:created":"2024-06-02T00:05:51.629Z","mgnl:created":"2024-05-20T22:28:41.503Z","industryTitle":"Medtech","mgnl:createdBy":"ajerrom","industryDetailPage":"cf38f255-b04e-4001-9fb8-3f6dabbb1435","mgnl:lastModified":"2026-04-14T13:50:45.869Z","industryImage":"jcr:f999dd54-4d38-4e87-853b-e0681b2d7184","mgnl:lastModifiedBy":"pnptc","@link":"https://public.dxp.playbook.vc/plug-and-play/medtech.html","@nodes":[]},"startupBatchesList-search":"","mgnl:lastModified":"2026-04-21T14:56:01.454Z","jcr:created":"2026-05-06T11:21:33.880Z","mgnl:created":"2026-04-21T14:56:01.339Z","mgnl:lastModifiedBy":"superuser","@nodes":[]},"@nodes":["fff86da1-0d1b-44a1-aa17-137435875106"]},"@nodes":["startupIndustriesList"]}